Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?".
作者信息
Sengul Ilker, Sengul Demet
机构信息
Giresun University, Faculty of Medicine, Division of Endocrine Surgery - Giresun, Turkey.
Giresun University, Faculty of Medicine, Department of General Surgery - Giresun, Turkey.
出版信息
Rev Assoc Med Bras (1992). 2022 Jul;68(7):973-974. doi: 10.1590/1806-9282.20220383.
Abstract
摘要
相似文献
1
Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?".关于《甲状腺学中对甲状腺影像报告和数据系统（TBSRTC）细胞学检查结果不确定的甲状腺结节进行治疗方案评估：是与否？补遗》的评论
Rev Assoc Med Bras (1992). 2022 Jul;68(7):973-974. doi: 10.1590/1806-9282.20220383.
2
Apropos of quality for fine-needle aspiration cytology of thyroid nodules with 22-, 23-, 25-, even 27-gauge needles and indeterminate cytology in thyroidology: an aide memory.关于使用22号、23号、25号甚至27号针进行甲状腺结节细针穿刺细胞学检查的质量以及甲状腺学中的不确定细胞学：助记法。
Rev Assoc Med Bras (1992). 2022 Aug;68(8):987-988. doi: 10.1590/1806-9282.20220498.
3
Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.美国甲状腺协会超声评估甲状腺结节细针抽吸术适应证的验证。
Thyroid. 2017 Aug;27(8):1077-1082. doi: 10.1089/thy.2016.0555. Epub 2017 Jul 18.
4
How to approach thyroid nodules with indeterminate cytology.如何处理细胞学不确定的甲状腺结节。
Ann Surg Oncol. 2010 Aug;17(8):2147-55. doi: 10.1245/s10434-010-0992-5. Epub 2010 Mar 9.
5
Use of strain ultrasound elastography versus fine-needle aspiration cytology for the differential diagnosis of thyroid nodules: a retrospective analysis.应用应变超声弹性成像与细针穿刺细胞学检查对甲状腺结节进行鉴别诊断：一项回顾性分析。
Clinics (Sao Paulo). 2020 Jun 22;75:e1594. doi: 10.6061/clinics/2020/e1594. eCollection 2020.
6
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
7
Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology.实时超声弹性成像：用于细化术前诊断甲状腺结节的有用工具，这些甲状腺结节的细胞学检查结果为不确定或非诊断性。
J Clin Endocrinol Metab. 2010 Dec;95(12):5274-80. doi: 10.1210/jc.2010-0901. Epub 2010 Sep 1.
8
Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules.在不确定甲状腺结节的管理中，核心针活检和超声检查结果的作用。
Head Neck. 2011 Feb;33(2):160-5. doi: 10.1002/hed.21414.
9
Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.超声特征与细胞学不确定的甲状腺结节中的恶性肿瘤相关。
Eur J Surg Oncol. 2014 Feb;40(2):182-6. doi: 10.1016/j.ejso.2013.11.015. Epub 2013 Dec 14.
10
Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.贝塞斯达系统细针吸取细胞学分类与甲状腺结节位置无关：单机构经验。
Acta Cytol. 2021;65(1):22-26. doi: 10.1159/000510175. Epub 2020 Sep 2.
引用本文的文献
1
Complications after thermal ablation for thyroid nodules across countries.各国甲状腺结节热消融术后的并发症
Front Endocrinol (Lausanne). 2025 Jul 29;16:1608164. doi: 10.3389/fendo.2025.1608164. eCollection 2025.
2
Oncocytic cell carcinoma of the thyroid with TERT promoter mutation presenting as asphyxia in an elderly: a case report.甲状腺嗜酸细胞癌伴 TERT 启动子突变致老年患者窒息 1 例报告
Front Endocrinol (Lausanne). 2024 Aug 16;15:1349114. doi: 10.3389/fendo.2024.1349114. eCollection 2024.
3
Is the neutrophil-to-lymphocyte "ratio"nale from head and neck to thyroidology for thyroidologists?: promise or passé?对甲状腺科医生而言，从头颈医学到甲状腺学，中性粒细胞与淋巴细胞的“比值”理论是否合理？是前景光明还是已过时？
Rev Assoc Med Bras (1992). 2024 May 20;70(5):e20231617. doi: 10.1590/1806-9282.20231617. eCollection 2024.
4
The Potential Role of Virus Infection in the Progression of Thyroid Cancer.病毒感染在甲状腺癌进展中的潜在作用。
World J Oncol. 2024 Jun;15(3):382-393. doi: 10.14740/wjon1830. Epub 2024 Apr 15.
5
Re: "American Thyroid Association and Thyroid Imaging Reporting and Data System developed by the American College of Radiology: which one is better at predicting malignancy risk?" in thyroidology.关于：“美国甲状腺协会与美国放射学会制定的甲状腺影像报告和数据系统：哪一个在预测恶性风险方面更出色？” 甲状腺学领域相关内容
Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20231584. doi: 10.1590/1806-9282.20231584. eCollection 2024.
6
Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology!伊万吉利，2023年《贝塞斯达甲状腺细胞病理学报告系统》已公布了亚分类：甲状腺学既往不咎！
Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20231511. doi: 10.1590/1806-9282.20231511. eCollection 2024.
7
Autoimmune Thyroid Disease and Differentiated Thyroid Carcinoma: A Review of the Mechanisms That Explain an Intriguing and Exciting Relationship.自身免疫性甲状腺疾病与分化型甲状腺癌：对一种有趣且引人关注的关系的机制综述
World J Oncol. 2024 Feb;15(1):14-27. doi: 10.14740/wjon1728. Epub 2023 Dec 9.
8
The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology.2023年甲状腺细胞病理学报告的贝塞斯达系统：在甲状腺学领域，“新的天地，细分不再有争议”。 （注：原文中“novi sub sole”可能有特定背景含义，这里直接按字面翻译，整体译文可能因该短语含义理解不同而稍显奇怪，需结合更多背景知识来准确把握。）
Rev Assoc Med Bras (1992). 2023 Nov 13;69(12):e20231124. doi: 10.1590/1806-9282.20231124. eCollection 2023.
9
Subdivision of intermediate suspicion, the 2021 K-TIRADS, and category III, indeterminate cytology, the 2017 TBSRTC, 2nd edition, in thyroidology: let bygones be bygones?甲状腺学中2021年K-TIRADS的中度可疑细分以及2017年第二版TBSRTC的III类、细胞学结果不确定：既往不咎？
Ultrasonography. 2023 Oct;42(4):600-601. doi: 10.14366/usg.23113. Epub 2023 Jul 25.
本文引用的文献
1
Focusing on thyroid nodules in suspense: 10-15 mm with repeat cytology, Category III, the Bethesda System for Reporting Thyroid Cytopathology, TBSRTC.关注可疑甲状腺结节：10 - 15毫米，需重复细胞学检查，III类，甲状腺细胞病理学报告的贝塞斯达系统（TBSRTC）
Rev Assoc Med Bras (1992). 2021 Feb;67(2):166-167. doi: 10.1590/1806-9282.67.02.20200828.
2
Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study.管理贝塞斯达III级和IV级甲状腺结节的治疗选择：一项加拿大多机构研究。
OTO Open. 2021 Jun 24;5(2):2473974X211015937. doi: 10.1177/2473974X211015937. eCollection 2021 Apr-Jun.
3
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival.甲状腺乳头状癌的新AJCC/TNM分期系统（第八版）：对总生存期和无复发生存期的临床及分子影响
Ann Transl Med. 2020 Jul;8(13):838. doi: 10.21037/atm.2020.03.80.
4
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
5
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南：美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
6
The Bethesda System for Reporting Thyroid Cytopathology.《甲状腺细胞病理学报告的贝塞斯达系统》
Thyroid. 2009 Nov;19(11):1159-65. doi: 10.1089/thy.2009.0274.
Zotero 插件